BAX
Price
$29.27
Change
+$0.11 (+0.38%)
Updated
Jan 2, 04:59 PM (EDT)
28 days until earnings call
BRKR
Price
$58.90
Change
+$0.28 (+0.48%)
Updated
Jan 2, 04:59 PM (EDT)
47 days until earnings call
Ad is loading...

BAX vs BRKR

Header iconBAX vs BRKR Comparison
Open Charts BAX vs BRKRBanner chart's image
Baxter International
Price$29.27
Change+$0.11 (+0.38%)
Volume$51.19K
CapitalizationN/A
Bruker
Price$58.90
Change+$0.28 (+0.48%)
Volume$32.87K
CapitalizationN/A
BAX vs BRKR Comparison Chart
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. BRKR commentary
Jan 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and BRKR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 03, 2025
Stock price -- (BAX: $29.16 vs. BRKR: $58.62)
Brand notoriety: BAX and BRKR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 78% vs. BRKR: 57%
Market capitalization -- BAX: $21.77B vs. BRKR: $12.93B
BAX [@Medical Specialties] is valued at $21.77B. BRKR’s [@Medical Specialties] market capitalization is $12.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileBRKR’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • BRKR’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than BRKR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while BRKR’s TA Score has 6 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 3 bearish.
  • BRKR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BRKR is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а +0.28% price change this week, while BRKR (@Medical Specialties) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.35%. For the same industry, the average monthly price growth was -1.04%, and the average quarterly price growth was +3.09%.

Reported Earning Dates

BAX is expected to report earnings on Jan 30, 2025.

BRKR is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Medical Specialties (-0.35% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than BRKR($12.9B). BAX has higher P/E ratio than BRKR: BAX (85.61) vs BRKR (32.04). BAX (0.000) and BRKR (0.000) have similar YTD gains . BAX has higher annual earnings (EBITDA): 1.67B vs. BRKR (676M). BAX has more cash in the bank: 3.19B vs. BRKR (488M). BRKR has less debt than BAX: BRKR (1.38B) vs BAX (14.4B). BAX has higher revenues than BRKR: BAX (14.8B) vs BRKR (2.96B).
BAXBRKRBAX / BRKR
Capitalization21.8B12.9B169%
EBITDA1.67B676M247%
Gain YTD0.0000.000-
P/E Ratio85.6132.04267%
Revenue14.8B2.96B499%
Total Cash3.19B488M655%
Total Debt14.4B1.38B1,043%
FUNDAMENTALS RATINGS
BAX vs BRKR: Fundamental Ratings
BAX
BRKR
OUTLOOK RATING
1..100
5329
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
8946
PRICE GROWTH RATING
1..100
6460
P/E GROWTH RATING
1..100
2276
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (5) in the Medical Specialties industry is somewhat better than the same rating for BRKR (51). This means that BAX’s stock grew somewhat faster than BRKR’s over the last 12 months.

BRKR's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as BAX (100). This means that BRKR’s stock grew similarly to BAX’s over the last 12 months.

BRKR's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for BAX (89). This means that BRKR’s stock grew somewhat faster than BAX’s over the last 12 months.

BRKR's Price Growth Rating (60) in the Medical Specialties industry is in the same range as BAX (64). This means that BRKR’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for BRKR (76). This means that BAX’s stock grew somewhat faster than BRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXBRKR
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 15 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
51%
Bullish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWT45.33N/A
N/A
California Water Service
ACI19.64N/A
N/A
Albertsons Companies
AMST4.75N/A
N/A
Amesite
FLGT18.47N/A
N/A
Fulgent Genetics
MPTI48.43N/A
N/A
M-tron Industries

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with SNN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then SNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
N/A
SNN - BAX
41%
Loosely correlated
N/A
TFX - BAX
40%
Loosely correlated
N/A
MDT - BAX
40%
Loosely correlated
N/A
ICUI - BAX
36%
Loosely correlated
N/A
BRKR - BAX
35%
Loosely correlated
N/A
More

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
N/A
A - BRKR
70%
Closely correlated
N/A
WAT - BRKR
59%
Loosely correlated
N/A
IQV - BRKR
56%
Loosely correlated
N/A
TMO - BRKR
52%
Loosely correlated
N/A
RVTY - BRKR
51%
Loosely correlated
N/A
More